SARS-CoV-2 Papain-like ProteaseTargeted Library

Summary of the technology

Using receptor based virtual screening OtavaResearchInstitute’s team designed the SARS-CoV-2 Papain-like Protease PLpro Targeted Library, which is contain 1058 stock compounds with predicted activity against this protease and ready for delivery.

Covid-19 Innovation Challenges by Innoget

Details of the Technology Offer

The papain-like protease PLpro is required for coronaviral replication as a part of NSP3 multi-domain protein. The ubiquitin and ISG15 PLpro are removed from the host cell proteins to prevent coronaviruses the formation of innate immune reactions. OtavaResearchInstitute’s team designed the SARS-CoV-2 Papain-like Protease PLpro Targeted Library (1058 stock compounds) using receptor based virtual screening.
The designed SARS-CoV-2 Papain-like Protease Targeted Library comprises only druglike compounds without PAINS compounds. The library is intended for screening projects to find new compounds with activity against SARS-CoV-2.
Feel free to contact us directly

Related Keywords

  • Applications for Health
  • Biological Sciences
  • Medicine, Human Health
  • Biostatistics, Epidemiology
  • Medical Research
  • Human vaccines
  • Emergency Medicine Technology
  • Biology / Biotechnology
  • Industrial Biotechnology
  • Infectious Diseases
  • Medical/health
  • Medical Health related
  • Diagnostic
  • Diagnostic services
  • Covid-19
  • coronavirus
  • sars-cov-2

About Covid-19 Innovation Challenges by Innoget

Ahead of the current Coronavirus outbreak, Innoget is fully committed to contributing to mobilizing scientific and expert communities to find a real solution to the Covid-19 pandemic. Therefore, we're supporting worldwide calls and programs that could help in any aspects of the coronavirus crisis.

Is your organization promoting or looking for innovation or research initiatives to mitigate the Covid-19 outbreak? Email us at covid19@innoget.com to list them.

Channeled through Innoget's online open innovation network, initiatives in the health, virology, medicine, or novel technologies applied to human health, among others, are listed and disseminated to Innoget members -ranging from hospitals, research institutes, scientists, businesses, and public administrations- and innovation partners worldwide.

Covid-19 Innovation Challenges by Innoget

Never miss an update from Covid-19 Innovation Challenges by Innoget

Create your free account to connect with Covid-19 Innovation Challenges by Innoget and thousands of other innovative organizations and professionals worldwide

Covid-19 Innovation Challenges by Innoget

Send a request for information
to Covid-19 Innovation Challenges by Innoget

Submit your request

About Technology Offers

Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.

Help

Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support